CND Life Sciences Awarded Grant to Advance Diagnostic Technology for Neurodegenerative Diseases
With this grant, CND will support the largest study of its kind to enhance the precision and clinical utility of its Syn-One Test, which is being adopted by neurologists to improve the diagnosis of neurodegenerative disorders, notably Parkinson’s.